Drug Detail:Sotyktu (Deucravacitinib)
Generic Name: DEUCRAVACITINIB 6mg
Dosage Form: tablet, film coated
Drug Class: Multikinase inhibitors
Recommended Evaluations and Immunizations Prior to Treatment Initiation
Evaluate patients for active and latent tuberculosis (TB) infection prior to initiating treatment with SOTYKTU. If positive, start treatment for TB prior to SOTYKTU use [see Warnings and Precautions (5.3)].
Update immunizations according to current immunization guidelines [see Warnings and Precautions (5.7)].